Penn-developed approach could limit toxicity of CAR T therapy in acute myeloid leukemia

(University of Pennsylvania School of Medicine) A new approach pioneered at the University of Pennsylvania's Abramson Cancer Center may provide a new path towards treating acute myeloid leukemia (AML) with CAR T cells.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news